Atossa Therapeutics (ATOS) Revenue (2011 - 2015)
Atossa Therapeutics (ATOS) posted quarterly Revenue of $1758.0 for Q4 2015, down 35.2% year-over-year from $2713.0 in Q4 2014, and down 35.2% quarter-over-quarter from $2713.0 in Q4 2014.
Atossa Therapeutics (ATOS) Revenue (2011 - 2015) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Revenue for 5 consecutive years, with $1758.0 the latest figure, recorded in Q4 2015.
- In Q4 2015, Revenue fell 35.2% year-over-year to $1758.0; the TTM figure through Sep 2016 stood at $1758.0 (down 35.2% YoY), while the FY2015 annual figure was $1758.0, down 95.62% from the prior year.
- Revenue eased to $1758.0 in Q4 2015 per ATOS's latest filing, from $2713.0 in the prior quarter.
- Across five years, Revenue topped out at $120488.0 in Q2 2013 and bottomed at -$361905.0 in Q4 2013.
- Historically, Revenue has averaged $6911.6 across 5 years, with a median of $6650.5 in 2014.
- Annual changes were most pronounced in 2012 — Revenue jumped 6463.73% — and 2013, when it sank 467.58%.
- Atossa Therapeutics' Revenue stood at $1500.0 in 2011, then surged by 6463.73% to $98456.0 in 2012, then tumbled by 467.58% to -$361905.0 in 2013, then surged by 100.75% to $2713.0 in 2014, then sank by 35.2% to $1758.0 in 2015.
- Business Quant data shows ATOS's Revenue at $1758.0 in Q4 2015, $2713.0 in Q4 2014, and $3426.0 in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Atossa Therapeutics | 23.16 Mn | 23.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 1,758.00 |
| Dec 31, 2014 | 2,713.00 |
| Sep 30, 2014 | 3,426.00 |
| Jun 30, 2014 | 9,875.00 |
| Mar 31, 2014 | 24,124.00 |
| Dec 31, 2013 | -361,905.00 |
| Sep 30, 2013 | 72,187.00 |
| Jun 30, 2013 | 120,488.00 |
| Mar 31, 2013 | 13,440.00 |
| Dec 31, 2012 | 98,456.00 |
| Sep 30, 2012 | 105,576.00 |
| Jun 30, 2012 | 3,125.00 |
| Mar 31, 2012 | 2,000.00 |
| Dec 31, 2011 | 1,500.00 |